Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19.
Eveline Y WuMichael J CampbellPublished in: Current cardiology reports (2021)
Studies demonstrate that up to 80% of children with MIS-C may have cardiac involvement on a spectrum of severity. Cardiac manifestations include myocarditis, coronary artery aneurysms, conduction abnormalities, and arrhythmias. Current treatments, including inotropic support, immunomodulatory therapy, and anti-coagulation, have been effective at resolving these cardiac findings in the majority of patients. COVID-19 can also cause myocarditis in the acute stage of illness and recent descriptions of COVID-19 vaccine myocarditis have occurred. Cardiac manifestations are common in MIS-C and should be assessed for at presentation and during the clinical course as indicated.
Keyphrases
- coronavirus disease
- left ventricular
- sars cov
- coronary artery
- end stage renal disease
- young adults
- chronic kidney disease
- newly diagnosed
- heart failure
- ejection fraction
- prognostic factors
- mesenchymal stem cells
- intensive care unit
- respiratory syndrome coronavirus
- pulmonary artery
- pulmonary hypertension
- congenital heart disease
- case control